Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Manal F. Abdelmalek"'
Autor:
Manal F. Abdelmalek, Jeongeun Hyun, Steven R. Patierno, Rebecca Caffrey, Cynthia A. Moylan, Muthana Al Abo, Anna Mae Diehl, Xiyou Zhou, Seh-Hoon Oh, Arun J. Sanyal, Kun Xiang, Rajesh Kumar Dutta, Raquel Maeso-Díaz, Jennifer A. Freedman
Publikováno v:
J Hepatol
Background & Aims Non-alcoholic fatty liver disease (NAFLD), the hepatic correlate of the metabolic syndrome, is a major risk factor for hepatobiliary cancer (HBC). Although chronic inflammation is thought to be the root cause of all these diseases,
Autor:
Robert H. Eckel, Leon A. Adams, Christos S. Mantzoros, Kenneth Cusi, Stephen A. Harrison, Fasiha Kanwal, Eugene E. Wright, Vincent Wai-Sun Wong, Hashem B. El-Serag, Rohit Loomba, Elisabetta Bugianesi, Manal F. Abdelmalek, Lee M. Kaplan, Kim Pfotenhauer, Jay H. Shubrook
Publikováno v:
Gastroenterology, vol 161, iss 5
Gastroenterology
Gastroenterology
Find AGA's NASH Clinical Care Pathway Appfor iOS and Android mobile devices at nash.gastro.org. Scan this QR code to be taken directly to the website.Nonalcoholic fatty liver disease (NAFLD) is becoming increasingly common, currently affecting approx
Autor:
Manal F. Abdelmalek, Keri A. Seymour
Publikováno v:
Current opinion in gastroenterology. 37(3)
Purpose of review Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in the United States and increasing globally. The progressive form of NAFLD, nonalcoholic steatohepatitis (NASH), can lead to cirrhosis and compl
Autor:
Brent A. Neuschwander-Tetri, Maria Lucia Pecoraro, Zobair M. Younossi, Arun J. Sanyal, Star Seyedkazemi, Vincent Wai-Sun Wong, Manal F. Abdelmalek, Pierre Bedossa, Naim Alkhouri, Jiacheng Yuan, Laurent Fischer, Quentin M. Anstee, Zachary Goodman, Frank Tacke
Publikováno v:
Contemporary clinical trials. 89
Introduction Nonalcoholic steatohepatitis (NASH) is a sub-classification of nonalcoholic fatty liver disease (NAFLD) characterized by increased risk of progressive liver fibrosis. Cenicriviroc (CVC) is a novel, orally administered, potent chemokine 2
Autor:
Kara Wegermann, Ayako Suzuki, Alisha M. Mavis, Manal F. Abdelmalek, Anna Mae Diehl, Cynthia A. Moylan
Publikováno v:
Hepatology. 73:1625-1625
We appreciate de Zegher and Ibanez calling attention to the association between non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS). As de Zegher and Ibanez rightly point out, NAFLD can occur in children and adolescents w
Autor:
David E. Bernstein, Lewis Teperman, Cen Wu, Rakhi Maiwall, Aijaz Ahmed, Ajay Duseja, Keyur Patel, Sanjaya K. Satapathy, Satish Kedia, Puneet Puri, Kalyan Ram Bhamidimarri, Paul J. Thuluvath, Prasun K. Jalal, Vincent Wai-Sun Wong, Ravi Ravinuthala, Uchenna Agbim, Ashwani K. Singal, Yu Jiang, Guruprasad P. Aithal, Manal F. Abdelmalek, Benedict Maliakkal
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation SocietyReferences. 26(1)
Morbid obesity is considered a relative contraindication for liver transplantation (LT). We investigated if body mass index (BMI; lean versus obese) is a risk factor for post-LT graft and overall survival in nonalcoholic steatohepatitis (NASH) and no
Autor:
Bill Tan, Eduardo B. Martins, Andrea D. Coviello, Naim Alkhouri, Ralph W. Charlton, Manal F. Abdelmalek
Publikováno v:
Diabetes. 68
Background: The treatment landscape of nonalcoholic steatohepatitis (NASH) is changing rapidly; drug safety is key as most patients will need long-term treatment. Cenicriviroc (CVC) is an oral antagonist of C-C chemokine receptors 2/5 in Phase 3 deve
Autor:
Stephanie Noviello, Stephen A. Harrison, Arun J. Sanyal, Rohit Loomba, Rose C. Christian, Edgar D. Charles, Manal F. Abdelmalek, Sudeep Kundu, Brent A. Neuschwander-Tetri, Eric Lawitz, Yi Luo, Dina Halegoua-DeMarzio
Publikováno v:
Lancet (London, England). 392(10165)
Summary Background Pegbelfermin (BMS-986036), a PEGylated human fibroblast growth factor 21 (FGF21) analogue, has previously been shown to improve markers of metabolism and liver fibrosis in obese patients with type 2 diabetes. In this phase 2a study
Autor:
Kimberly P. Newton, Haruna S. Feldman, Christina D. Chambers, Laura Wilson, Cynthia Behling, Jeanne M. Clark, Jean P. Molleston, Naga Chalasani, Arun J. Sanyal, Mark H. Fishbein, Joel E. Lavine, Jeffrey B. Schwimmer, Stephanie H. Abrams, Sarah Barlow, Ryan Himes, Rajesh Krisnamurthy, Leanel Maldonado, Rory Mahabir, April Carr, Kimberlee Bernstein, Kristin Bramlage, Kim Cecil, Stephanie DeVore, Rohit Kohli, Kathleen Lake, Daniel Podberesky, Alex Towbin, Stavra Xanthakos, Daniela Allende, Srinivasan Dasarathy, Arthur J. McCullough, Mangesh Pagadala, Rish Pai, Cha'Ron Winston, Gerald Behr, Jay H. Lefkowitch, Ali Mencin, Elena Reynoso, Manal F. Abdelmalek, Mustafa Bashir, Stephanie Buie, Anna Mae Diehl, Cynthia Guy, Christopher Kigongo, David Malik, Yi-Ping Pan, Dawn Piercy, Mariko Kopping, Tyler Thrasher, Adina Alazraki, Rebecca Cleeton, Maria Cordero, Albert Hernandez, Saul Karpen, Jessica Cruz Munos, Nicholas Raviele, Miriam Vos, Molly Bozic, Oscar W. Cummings, Samer Gawrieh, Ann Klipsch, Emily Ragozzino, Linda Ragozzino, Kumar Sandrasegaran, Girish Subbarao, Raj Vuppalanchi, Laura Walker, Kimberly Kafka, Ann Scheimann, Joy Ito, Saeed Mohammad, Cynthia Rigsby, Lisa Sharda, Peter F. Whitington, Theresa Cattoor, Jose Derdoy, Janet Freebersyser, Ajay Jain, Debra King, Jinping Lai, Pat Osmack, Joan Siegner, Susan Stewart, Brent A. Neuschwander-Tetri, Susan Torretta, Kristina Wriston, Fereshteh Assadian, Vanessa Barone, Maria Cardona Gonzalez, Jodie Davila, Oren Fix, Kelly Anne Hennessey, Kris V. Kowdley, Kacie Lopez, Erik Ness, Michelle Poitevin, Nicholas Procaccini, Brook Quist, Alana Saddic, Cara Wiseman, Matthew Yeh, Susan S. Baker, Diana Lopez-Graham, Sonja Williams, Lixin Zhu, Jonathan Africa, Brandon Ang, Hannah Awai, Archana Bhatt, Craig Bross, Jennifer Collins, Janis Durelle, Kathryn Harlow, Rohit Loomba, Michael Middleton, Kimberly Newton, Melissa Paiz, Claude Sirlin, Patricia Ugalde-Nicalo, Mariana Dominguez Villarreal, Bradley Aouizerat, Nathan M. Bass, Danielle Brandman, Jesse Courtier, Linda D. Ferrell, Natasha Feier, Ryan Gill, Bilal Hameed, Camille Langlois, Jacqueline Maher, Emily Rothbaum Perito, Claudia Ramos, Philip Rosenthal, Norah Terrault, Patrika Tsai, Ashley Ungermann, Pradeep Atla, Brandon Croft, Rebekah Garcia, Sonia Garcia, Muhammad Sheikh, Mandeep Singh, Kara Cooper, Simon Horslen, Evelyn Hsu, Karen Murray, Randolph Otto, Melissa Young, Sherry Boyett, Laura Carucci, Melissa J. Contos, Sherri Kirwin, Kenneth Kraft, Velimir A.C. Luketic, Puneet Puri, Jolene Schlosser, Mohammad S. Siddiqui, Elizabeth M. Brunt, Kathryn Fowler, David E. Kleiner, Sherry Brown, Edward C. Doo, Jay H. Hoofnagle, Patricia R. Robuck, Averell Sherker, Rebecca Torrance, Patricia Belt, Michele Donithan, Erin Hallinan, Milana Isaacson, Kevin P. May, Laura Miriel, Alice Sternberg, James Tonascia, Mark Van Natta, Katherine Yates
To examine the distribution of birth weight in children with nonalcoholic fatty liver disease (NAFLD) compared with the general US population, and to investigate the relationship between birth weight and severity of NAFLD.A multicenter, cross-section
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::691fa97c7817be495a652f03583f71e7
https://europepmc.org/articles/PMC5533631/
https://europepmc.org/articles/PMC5533631/
Autor:
Mitchell L. Shiffman, A. Sanyal, Anna Mae Diehl, Stephen A. Harrison, John G. McHutchison, N. Afdhal, Mani Subramanian, Stephen H. Caldwell, Raul Aguilar, B. Mccolgan, Manal F. Abdelmalek, Zachary Goodman, Vlad Ratziu, Don C. Rockey, Paul J. Thuluvath, Jaime Bosch, Reem Ghalib, R.P. Myers, Catherine Jia
Publikováno v:
Journal of Hepatology. 66:S159-S160